Adrenocorticotrophic potency of long-acting corticotrophin preparations during long-term treatment of neurological patients.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects*; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000494:pharmacology*; D000328:Adult; D005260:Female; D005780:Gelatin; D006801:Humans; D006878:Hydroxides; D008134:Long-Term Care; D008297:Male; D008747:Methylcellulose; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D014677:Pharmaceutical Vehicles; D010693:Phloretin; D010710:Phosphates; D011128:Polyradiculopathy / Q000188:drug therapy*; D013997:Time Factors; D015032:Zinc
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006878:Hydroxides; D014677:Pharmaceutical Vehicles; D010710:Phosphates; D005780:Gelatin; D000324:Adrenocorticotropic Hormone; D008747:Methylcellulose; D015032:Zinc; D010693:Phloretin